AFFINITY ASSET ADVISORS, LLC Celldex Therapeutics, Inc. Transaction History

AFFINITY ASSET ADVISORS, LLC portfolio value:

$0
portfolio value

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +100.00% 40K shares 1.17M $28.11 80K
Q3 2022 call Decrease -100.00% -145K shares -3.90M $28.11 0
Q2 2022 call Increase 0.00% 145K shares 3.90M $26.96 145K
Q2 2022 share Decrease -68.00% -85K shares -3.18M $26.96 40K
Q1 2022 share Increase +25.00% 25K shares 394K $34.06 125K
Q4 2021 share Increase +149.04% 59.84K shares 1.69M $38.9 100K
Q3 2021 share Decrease -19.69% -9.84K shares 496K $53.99 40.15K
Q2 2021 share Decrease -61.54% -80K shares -1.00M $33.44 50K
Q1 2021 share Increase +73.33% 55K shares 1.36M $20.6 130K
Q4 2020 share Increase 0.00% 75K shares 1.31M $17.52 75K